Conducted in August 2015 by Wakefield Research on behalf of the Gout
& Uric Acid Education Society.
By the end of 5 years, survival in the control group was still above 95%, whereas survival rates in the gout
group had fallen to between 85% and 90%.
It is important to note that corticosteroids have many adverse effects and are often misused to the detriment of the gout
Heywood in Sanditon hold gout, together with travel to spas, to be a symbol of luxury unavailable to them: "They had very pretty Property--enough, had their family been of reasonable Limits to have allowed them a very gentlemanlike share of Luxuries & Change--enough for them to have indulged in a new Carriage & better roads, an occasional month at Tunbridge Wells, & symptoms of the Gout
and a Winter at Bath" (MW 373-74).
This can be crucial, as having one attack prompts a 50/50 chance of another and if further attacks occur, the gout
can become more difficult to deal with.
The Pharmacor report entitled Gout forecasts that the chronic gout segment of the gout
market will double from $500 million in 2011 to more than $1 billion in 2021 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.
But as gout continues to affect a growing number of Americans, new research[i] from the Gout
& Uric Acid Education Society (GUAES) reveals that very few adults understand the importance of regular uric acid testing, let alone the recommended levels for preventing gout and other health issues.
Pillinger reported being the recipient of research grants from Takeda, which markets colchicine (Colcrys), and Savient, which markets the gout
drug pegloticase (Krystexxa).
The primary objectives of this study are to evaluate the unmet need in managing and treating gout, quantify the gout
patient population refractory to UAL therapy, quantify current/intended future use of medications for treating the condition, identify key product attributes for UAL therapies which drive the prescribing decision and evaluate the reaction, advantages/disadvantages and likelihood to prescribe the newest agent, Krystexxa.
para]]Gensco Laboratories Supports the Gout
& Uric Acid Education Society's Gout Awareness Day on Friday, May 22, 2015[[/para]]
Since more than half of the gout
cases in our cohort occurred among those with hypertension, the potential impact of the prevention of hypertension on the incidence of gout is substantial," Dr.
As the new report* explains, pharmaceutical companies are scrambling to expand into the gout
market, as it is now the most common form of inflammatory joint disease in men and women aged over 40 years, caused by genetic metabolic defects, kidney impairment, alcohol abuse and even meat-heavy diets.